Lexington supports acquisition by Clinical Innovations Inc of Brenner Medical GmbH

Lexington provided full buy side advice to Clinical Innovations

Lexington supports acquisition by Clinical Innovations Inc of Brenner Medical GmbH

July 27, 2017

L‍exington is pleased to have advised Salt Lake City based Clinical Innovations Inc upon its acquisition of Brenner Medical GmbH.

‍Clinical Innovations is one of the largest medical device companies exclusively focussed on pregnancy, labour and the neonatal intensive care unit. Munich based Brenner Medical has been a strong partner of Clinical innovations for many years and offers innovative products for the fields of obstetrics and gynaecology.

‍The acquisition broadens Clinical Innovations' infrastructure in Europe and overall global presence. The purchase will also provide a platform to improve product reach in Germany and builds on the successful creation of Clinical Innovations European subsidiary which was formed in the last three years.

‍Lexington was delighted to have worked with the Clinical Innovations teams in both the USA and the UK to deliver the transaction which was in line with the original timetable set for completion.

‍Gary Partridge who led the team alongside Thomas Edwards said "Lexington navigated Clinical Innovations through this important step in enhancing its commercial platform. We drew upon our significant personal experiences of completing international acquisitions and, in particular, advising buyers from the USA to deliver a tailored professional service to their Deal team"

‍Clinical Innovations is a Pritzker Group Private Capital company which acquired North America based middle-market companies with leading positions in the manufactured products, services and healthcare sectors.